at the present time the majority recently new vaccine candidates are still in the proclinical development phase or beginning clinical development
At the present time, the majority of recently developed new vaccine candidates are still in the preclinical development phase or beginning clinical development.
At the present time, the majority recently new vaccine candidates are still in the preclinical development phase or beginning clinical development.